Please assess the completion status of the following clinical trial:

Trial Title: Measuring the Effects of Continuous Dopaminergic Stimulation on Nocturnal Movements in Parkinson's Disease

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients with idiopathic PD (defined by UK Brain Bank criteria)~* Patients who will start treatment with rotigotine~* Hoehn \& Yahr stage II - IV~* Subjective sleep problems most likely caused by nocturnal hypokinesia, based on clinical interview~Exclusion Criteria:~* Other significant causes for nocturnal motor symptoms which are not dopamine-responsive~* Previous surgery for PD~* Mini- mental state examination score \< 25~* Concurrent hallucination or psychosis~* History of skin hypersensitivity to adhesives or other transdermals

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- parkinson's disease, nocturnal hypokinesia, rotigotine (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).